
Stéphane Bancel
Fortune : 1 052 M $ au 31/05/2026

Fortune : 1 052 M $ au 31/05/2026
Stphane Bancel est un homme d'affaires qui a été à la tête de 5 entreprises différentes. Il occupe actuellement les fonctions de directeur général et de directeur de Moderna, Inc., de directeur général et de directeur de ModernaTX, Inc. (une filiale de Moderna, Inc.) et de directeur général de Moderna SpA. M. Bancel est également membre du conseil d'administration de 5 autres sociétés. Au cours de sa carrière passée, Stphane Bancel a occupé les postes de président chez BG Medicine, Inc. et de directeur exécutif de la stratégie de fabrication mondiale chez Eli Lilly & Co. Principal chez Eli Lilly & Co. Ltd. et Managing Director chez Eli Lilly Benelux SA (toutes deux filiales d'Eli Lilly & Co.) et Chief Executive Officer chez bioMrieux SA. Stphane Bancel a obtenu un diplôme d'études supérieures de l'université du Minnesota, un diplôme d'études supérieures de l'école Centrale Paris et un MBA de la Harvard Business School.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MODERNA, INC. 5,54 % | 09/03/2026 | 21 963 357 ( 5,54 % ) | 1 036 M $ | 31/05/2026 |
| 02/03/2026 | 1 184 989 ( 0,92 % ) | 16 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MODERNA, INC. | Directeur Général | 01/03/2011 |
| GENERATE BIOMEDICINES, INC. | Directeur/Membre du Conseil | 01/09/2019 |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Private Equity Investor | 01/01/2013 |
Moderna SpA
Moderna SpA Food DistributorsDistribution Services Wholesales food and non-food products | Directeur Général | - |
Qiagen SRL
Qiagen SRL Medical SpecialtiesHealth Technology Provides molecular testing solutions | Directeur/Membre du Conseil | - |
Indigo Ag, Inc.
Indigo Ag, Inc. BiotechnologyHealth Technology Develops biological and digital technologies | Directeur/Membre du Conseil | 02/08/2020 |
Museum of Science
Museum of Science Other Consumer ServicesConsumer Services Operates as a museum | Directeur/Membre du Conseil | - |
QIAGEN GmbH
QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services Provides products for preanalytical sample preparation and molecular diagnostics solutions | Directeur/Membre du Conseil | - |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Directeur Général | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 23 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
QIAGEN NV
QIAGEN NV Medical SpecialtiesHealth Technology Manufactures and distributes sample and assay technology products for pre-analytical sample preparations | Health Technology |
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Discovers, develops and commercializes molecular diagnostic tests for cancer patients | Health Services |
BG Medicine, Inc.
BG Medicine, Inc. Medical SpecialtiesHealth Technology Develops and manufactures diagnostic test kits | Health Technology |
Targanta Therapeutics Corp.
Targanta Therapeutics Corp. BiotechnologyHealth Technology Discovers and develops novel antibacterial pro drugs | Health Technology |
Tafkak, Inc.
Tafkak, Inc. Miscellaneous Commercial ServicesCommercial Services Provides genome sequencing and analysis solutions | Commercial Services |
bioMérieux SA
bioMérieux SA Medical SpecialtiesHealth Technology Develops biotechnological products specializing in in-vitro diagnostics and infectious diseases | Health Technology |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eli Lilly & Co. Ltd.
Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical health care solutions | Health Technology |
QIAGEN GmbH
QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services Provides products for preanalytical sample preparation and molecular diagnostics solutions | Commercial Services |
École Centrale Paris
École Centrale Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Museum of Science
Museum of Science Other Consumer ServicesConsumer Services Operates as a museum | Consumer Services |
Eli Lilly Benelux SA
Eli Lilly Benelux SA Pharmaceuticals: MajorHealth Technology Engages in discovery and development of medicines | Health Technology |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Health Technology |
Qiagen SRL
Qiagen SRL Medical SpecialtiesHealth Technology Provides molecular testing solutions | Health Technology |
Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indigo Ag, Inc.
Indigo Ag, Inc. BiotechnologyHealth Technology Develops biological and digital technologies | Health Technology |
Moderna, Inc.
Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Moderna SpA
Moderna SpA Food DistributorsDistribution Services Wholesales food and non-food products | Distribution Services |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Operates as a clinical-stage generative biology company that provides biotechnology and drug design & development services | Health Technology |
Moderna Holding BV
Moderna Holding BV MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national